{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Fluticasone+250+mcg", "query": { "intervention": "Fluticasone 250 mcg" }, "page_size": 10 }, "pagination": { "page": 1, "page_size": 10, "total_count": 37, "total_pages": 4, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Fluticasone+250+mcg&page=2&page_size=10", "previous_page_url": null }, "source": "remote", "last_synced_at": "2026-09-23T09:36:46.257Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT01836471", "title": "A Study to Assess the Effect of QAW039 in Non-atopic Asthmatic Patients", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Asthma" ], "interventions": [ { "name": "QAW039", "type": "DRUG" }, { "name": "Placebo QAW039", "type": "DRUG" }, { "name": "Fluticasone 250 mcg", "type": "DRUG" }, { "name": "Fluticasone 100 mcg", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Novartis Pharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 345, "start_date": "2013-05", "completion_date": "2016-02", "has_results": true, "last_update_posted_date": "2017-03-20", "last_synced_at": "2026-09-23T09:36:46.257Z", "location_count": 30, "location_summary": "Encinitas, California • Huntington Beach, California • Los Angeles, California + 24 more", "locations": [ { "city": "Encinitas", "state": "California" }, { "city": "Huntington Beach", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Mission Viejo", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT01836471" }, { "nct_id": "NCT00452348", "title": "A 12-Month Study Comparing Fluticasone Propionate/Salmeterol (ADVAIR) DISKUS Combination Product 250/50mcg Twice Daily To Fluticasone Propionate (FLOVENT) DISKUS 250 mcg Twice Daily In Symptomatic Patients With Asthma", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Asthma" ], "interventions": [ { "name": "Fluticasone Propionate/salmeterol xinofoate 250/50 mcg BID", "type": "DRUG" }, { "name": "Fluticasone propionate 250 mcg BID", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "GlaxoSmithKline", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "12 Years", "maximum_age": null, "sex": "ALL", "summary": "12 Years and older" }, "enrollment_count": 628, "start_date": "2007-05", "completion_date": "2009-04", "has_results": true, "last_update_posted_date": "2016-12-09", "last_synced_at": "2026-09-23T09:36:46.257Z", "location_count": 58, "location_summary": "Birmingham, Alabama • Mobile, Alabama • Fresno, California + 54 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Birmingham", "state": "Alabama" }, { "city": "Mobile", "state": "Alabama" }, { "city": "Fresno", "state": "California" }, { "city": "Fullerton", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00452348" }, { "nct_id": "NCT03002389", "title": "Hyperpolarized Xenon-129 MRI: a New Multi-dimensional Biomarker to Determine Pulmonary Physiologic Responses to COPD Therapeutics", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Chronic Obstructive Pulmonary Disease" ], "interventions": [ { "name": "Anoro Ellipta", "type": "DRUG" }, { "name": "Arnuity Ellipta", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "University of Virginia", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "85 Years", "sex": "ALL", "summary": "18 Years to 85 Years" }, "enrollment_count": 95, "start_date": "2017-11-05", "completion_date": "2028-01-31", "has_results": false, "last_update_posted_date": "2024-11-18", "last_synced_at": "2026-09-23T09:36:46.257Z", "location_count": 1, "location_summary": "Keswick, Virginia", "locations": [ { "city": "Keswick", "state": "Virginia" } ], "official_url": "https://clinicaltrials.gov/study/NCT03002389" }, { "nct_id": "NCT01967173", "title": "Best African American Response to Asthma Drugs", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Asthma" ], "interventions": [ { "name": "Flovent Diskus® 100 mcg", "type": "DRUG" }, { "name": "Flovent Diskus® 250 mcg", "type": "DRUG" }, { "name": "Flovent Diskus® 500 mcg", "type": "DRUG" }, { "name": "Advair Diskus® 100/50 mcg", "type": "DRUG" }, { "name": "Advair Diskus® 250/50 mcg", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Milton S. Hershey Medical Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "5 Years", "maximum_age": null, "sex": "ALL", "summary": "5 Years and older" }, "enrollment_count": 574, "start_date": "2014-02", "completion_date": "2017-07-01", "has_results": true, "last_update_posted_date": "2018-11-15", "last_synced_at": "2026-09-23T09:36:46.257Z", "location_count": 28, "location_summary": "Tucson, Arizona • Oakland, California • San Francisco, California + 16 more", "locations": [ { "city": "Tucson", "state": "Arizona" }, { "city": "Oakland", "state": "California" }, { "city": "San Francisco", "state": "California" }, { "city": "San Francisco", "state": "California" }, { "city": "Denver", "state": "Colorado" } ], "official_url": "https://clinicaltrials.gov/study/NCT01967173" }, { "nct_id": "NCT01124422", "title": "Fluticasone Propionate/Salmeterol Combination 250/50 DISKUS in the Exercise Endurance Time in Patients With Chronic Obstructive Pulmonary Disease", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Pulmonary Disease, Chronic Obstructive" ], "interventions": [ { "name": "fluticasone propionate/salmeterol inhalation powder DISKUS 250/50", "type": "DRUG" }, { "name": "tiotropium bromide inhalation powder HandiHaler", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "GlaxoSmithKline", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "40 Years", "maximum_age": null, "sex": "ALL", "summary": "40 Years and older" }, "enrollment_count": 255, "start_date": "2010-07-19", "completion_date": "2011-05-02", "has_results": true, "last_update_posted_date": "2017-11-08", "last_synced_at": "2026-09-23T09:36:46.257Z", "location_count": 18, "location_summary": "Birmingham, Alabama • Phoenix, Arizona • Torrance, California + 15 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Torrance", "state": "California" }, { "city": "Fort Collins", "state": "Colorado" }, { "city": "Hartford", "state": "Connecticut" } ], "official_url": "https://clinicaltrials.gov/study/NCT01124422" }, { "nct_id": "NCT01576718", "title": "A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler (Puffer) in Adolescents and Adults Who Have Asthma That is Not Controlled by High Dose Inhaled Corticosteroid Asthma Medications", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Asthma" ], "interventions": [ { "name": "Fp MDPI", "type": "DRUG" }, { "name": "Placebo MDPI", "type": "OTHER" }, { "name": "Flovent Diskus", "type": "DRUG" }, { "name": "albuterol/salbutamol", "type": "DRUG" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "Teva Branded Pharmaceutical Products R&D, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "12 Years", "maximum_age": null, "sex": "ALL", "summary": "12 Years and older" }, "enrollment_count": 889, "start_date": "2012-04", "completion_date": "2013-10", "has_results": true, "last_update_posted_date": "2018-05-08", "last_synced_at": "2026-09-23T09:36:46.257Z", "location_count": 148, "location_summary": "Birmingham, Alabama • Homewood, Alabama • Goodyear, Arizona + 114 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Homewood", "state": "Alabama" }, { "city": "Goodyear", "state": "Arizona" }, { "city": "Tucson", "state": "Arizona" }, { "city": "Bakersfield", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT01576718" }, { "nct_id": "NCT02251379", "title": "Environmental Control as Add-on Therapy in Childhood Asthma", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Asthma" ], "interventions": [ { "name": "Flovent Diskus", "type": "DRUG" }, { "name": "Home Environmental Intervention", "type": "OTHER" }, { "name": "Advair Diskus", "type": "DRUG" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "Johns Hopkins University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "5 Years", "maximum_age": "17 Years", "sex": "ALL", "summary": "5 Years to 17 Years" }, "enrollment_count": 155, "start_date": "2014-10-01", "completion_date": "2018-11", "has_results": true, "last_update_posted_date": "2019-11-20", "last_synced_at": "2026-09-23T09:36:46.257Z", "location_count": 1, "location_summary": "Baltimore, Maryland", "locations": [ { "city": "Baltimore", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT02251379" }, { "nct_id": "NCT02593123", "title": "Adoptive Immunotherapy in Relapsed Hematological Malignancy: Early GVHD Prophylaxis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Hodgkin's Lymphoma", "Lymphoid Leukemia", "Lymphoma", "Leukemia", "Myeloma", "Acute Lymphocytic Leukemia", "Non Hodgkin Lymphoma", "Chronic Lymphocytic Leukemia", "Multiple Myeloma", "Chronic Myelogenous Leukemia", "Myelodysplastic Syndromes", "Recurrent Acute Myeloid Leukemia, Adult", "Recurrent Hodgkin Lymphoma", "Recurrent Non-Hodgkin Lymphoma", "Recurrent Plasma Cell Myeloma", "Recurrent Chronic Lymphocytic Leukemia", "Recurrent Chronic Myelogenous Leukemia", "Acute Myelogenous Leukemia" ], "interventions": [ { "name": "mycophenolate mofetil", "type": "DRUG" }, { "name": "Sargramostim", "type": "BIOLOGICAL" }, { "name": "Filgrastim", "type": "BIOLOGICAL" } ], "intervention_types": [ "DRUG", "BIOLOGICAL" ], "sponsor": "Virginia Commonwealth University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "74 Years", "sex": "ALL", "summary": "18 Years to 74 Years" }, "enrollment_count": 31, "start_date": "2015-11-04", "completion_date": "2022-03-18", "has_results": true, "last_update_posted_date": "2023-01-23", "last_synced_at": "2026-09-23T09:36:46.257Z", "location_count": 1, "location_summary": "Richmond, Virginia", "locations": [ { "city": "Richmond", "state": "Virginia" } ], "official_url": "https://clinicaltrials.gov/study/NCT02593123" }, { "nct_id": "NCT00235053", "title": "Study to Assess the Incidence of Local Oropharyngeal and Laryngeal Adverse Effects of Advair DISKUS 250/50 mcg BID", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Asthma", "Candidiasis, Oral", "Voice Disorders" ], "interventions": [ { "name": "fluticasone/salmeterol DISKUS 250/50", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Allergy & Asthma Medical Group & Research Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "55 Years", "sex": "ALL", "summary": "18 Years to 55 Years" }, "enrollment_count": 13, "start_date": "2005-08", "completion_date": "2005-11", "has_results": false, "last_update_posted_date": "2024-01-30", "last_synced_at": "2026-09-23T09:36:46.257Z", "location_count": 1, "location_summary": "San Diego, California", "locations": [ { "city": "San Diego", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00235053" }, { "nct_id": "NCT02301975", "title": "An Efficacy and Safety Study of Fluticasone Furoate/Vilanterol 100/25 Microgram (mcg) Inhalation Powder, Fluticasone Propionate/Salmeterol 250/50 mcg Inhalation Powder, and Fluticasone Propionate 250 mcg Inhalation Powder in Adults and Adolescents With Persistent Asthma", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Asthma" ], "interventions": [ { "name": "Fluticasone Furoate/Vilanterol 100/25 mcg via ELLIPTA inhaler", "type": "DRUG" }, { "name": "Placebo inhalation powders via ELLIPTA inhaler", "type": "DRUG" }, { "name": "Fluticasone Propionate/Salmeterol 250/50 mcg via ACCUHALER/DISKUS inhaler", "type": "DRUG" }, { "name": "Placebo inhalation powder via ACCUHALER/DISKUS inhaler", "type": "DRUG" }, { "name": "Fluticasone Propionate 250 mcg via ACCUHALER/DISKUS inhaler", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "GlaxoSmithKline", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "12 Years", "maximum_age": null, "sex": "ALL", "summary": "12 Years and older" }, "enrollment_count": 1526, "start_date": "2015-03-01", "completion_date": "2016-11-25", "has_results": true, "last_update_posted_date": "2018-08-06", "last_synced_at": "2026-09-23T09:36:46.257Z", "location_count": 34, "location_summary": "Huntington Beach, California • Riverside, California • Rolling Hills Estates, California + 30 more", "locations": [ { "city": "Huntington Beach", "state": "California" }, { "city": "Riverside", "state": "California" }, { "city": "Rolling Hills Estates", "state": "California" }, { "city": "San Diego", "state": "California" }, { "city": "Upland", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT02301975" } ] }